Findings from our 2022 Global Survey show that MSLs are engaging externally as early as Phase 1 of the clinical development programme. This finding led to a conversation between Helen Kane, Paul Reynolds, Sanda Rocak & Esther Nzenza, in which they started to explore what MSLs and the wider team needed to know and do to be effective in early life-cycle engagement. It is evident that there is significant scope to collaborate earlier across medical affairs, marketing, market access and clinical development to fully unleash the power of all four. From that single conversation grew the idea for a webinar where they would meet to discuss a number of relevant questions around the opportunities and challenges which can exist for any organisation.

One MSL Community Team

https://www.onemsl.com/